isosorbide dinitrate

FDA Drug Profile — Isosorbide Dinitrate, ISOSORBIDE DINITRATE

Drug Details

Generic Name
isosorbide dinitrate
Brand Names
Isosorbide Dinitrate, ISOSORBIDE DINITRATE
Application Number
ANDA087537
Sponsor
Endo USA, Inc.
NDC Codes
19
Dosage Forms
TABLET
Routes
ORAL
Active Ingredients
ISOSORBIDE DINITRATE

Indications and Usage

1 INDICATIONS AND USAGE Isosorbide dinitrate and hydralazine hydrochloride tablets are a combination of isosorbide dinitrate, a nitrate vasodilator, and hydralazine hydrochloride, an arteriolar vasodilator, indicated for: the treatment of heart failure as an adjunct therapy to standard therapy in self-identified black patients to improve survival, prolong time to hospitalization for heart failure and to improve patient-reported functional status ( 1.1 ) Limitations of use: There is little experience in patients with NYHA class IV heart failure ( 1.2 ) 1.1 Treatment of Heart Failure in Self-identified Black Patients Isosorbide dinitrate and hydralazine hydrochloride tablets are indicated for the treatment of heart failure as an adjunct to standard therapy in self-identified black patients to improve survival, to prolong time to hospitalization for heart failure, and to improve patient-reported functional status. 1.2 Limitations of Use There is little experience in patients with NYHA class IV heart failure.